Aziz Mottiwala is CCO at Tarsus Pharmaceuticals, Inc. (TARS). They have made 10 open-market trades across 1 company since 2021, most recently 2026-03-19.
CIK 0001788542
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 10 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TARS | 61,480 | $4.2M |
Shares reported on the most recent Form 4, priced at the 2026-03-19 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TARS | SELL | 2026-03-17 | 2026-03-19 | $68.36 | $893K | +5.1% | -1.2% | -6.4% |
| TARS | SELL · 10b5-1 | 2025-06-09 | 2025-06-11 | $43.76 | $766K | +1.3% | -4.2% | +38.2% |
| TARS | SELL | 2025-03-18 | 2025-03-20 | $47.88 | $1.0M | -0.8% | -1.6% | -16.7% |
| TARS | SELL | 2024-03-18 | 2024-03-19 | $30.60 | $292K | +13.2% | +3.7% | -8.9% |
| TARS | SELL · 10b5-1 | 2023-07-19 | 2023-07-21 | $20.05 | $48K | -29.3% | -29.9% | -46.6% |
| TARS | SELL · 10b5-1 | 2023-06-08 | 2023-06-12 | $20.00 | $2K | +0.3% | -5.1% | -6.7% |
| TARS | SELL · 10b5-1 | 2023-06-06 | 2023-06-08 | $19.00 | $88K | -5.8% | -8.6% | -17.2% |
| TARS | SELL | 2023-03-21 | 2023-03-23 | $12.55 | $14K | +3.7% | +21.4% | +52.5% |
| TARS | SELL | 2023-03-17 | 2023-03-21 | $12.94 | $9K | -2.3% | +12.6% | +48.2% |
| TARS | SELL | 2023-03-16 | 2023-03-17 | $13.43 | $5K | -0.9% | -2.4% | +44.7% |
| TARS | SELL | 2022-11-15 | 2022-11-17 | $17.72 | $243K | -0.1% | -16.1% | -8.9% |
| TARS | SELL | 2021-11-08 | 2021-11-10 | $28.11 | $106K | -9.9% | -15.3% | -38.4% |
| TARS | SELL · 10b5-1 | 2021-11-04 | 2021-11-08 | $28.04 | $3K | -9.8% | -11.2% | -38.6% |
| TARS | SELL | 2021-11-02 | 2021-11-04 | $26.77 | $307K | -3.8% | -11.7% | -35.8% |
| TARS | SELL | 2021-09-10 | 2021-09-14 | $22.15 | $115K | -1.3% | +21.8% | +11.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.